Drug intelligence / Profile preview

Prozap

Development stage
Unknown
Lead developer
Neogen
Modality
Small Molecules
Administration
Oral
01

Overview

Prozap is a trade name used for several distinct chemical and pharmaceutical products, making it a non-specific identifier globally. In the pharmaceutical sector, it most commonly refers to two different generic medications: omeprazole and fluoxetine. In Mexico and other Latin American markets, Prozap is a brand of omeprazole manufactured by Laboratorios Senosiain. Omeprazole is a proton pump inhibitor (PPI) that works by irreversibly inhibiting the H+/K+-ATPase enzyme system (the gastric proton pump) in the parietal cells of the stomach, thereby reducing gastric acid secretion. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, and hypersecretory conditions like Zollinger-Ellison syndrome. In the Philippines, Prozap is a brand of fluoxetine marketed by Westmont Pharmaceuticals (a division of Unilab). Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that increases extracellular levels of serotonin by limiting its reabsorption into the presynaptic cell, used to treat major depressive disorder, obsessive-compulsive disorder (OCD), and panic disorder. Additionally, the Prozap name is used by Neogen Corporation for a variety of agricultural and veterinary pest control products, including rodenticides containing zinc phosphide and insecticides containing dichlorvos or pyrethrins.

Brand names
Prozap
Other names
omeprazolefluoxetine
02

Targets

SERT (Sodium-dependent serotonin transporter)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on Prozap.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prozap.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call